XML 39 R81.htm IDEA: XBRL DOCUMENT v2.4.1.9
Stock Incentive Plans (Details 3) (Restricted Stock [Member], USD $)
12 Months Ended
Dec. 31, 2014
Restricted Stock [Member]
 
Non-vested stock incentive awards  
Beginning Balance, Non-vested, shares 788,000hcn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsNonvestedNumber
/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis
= us-gaap_RestrictedStockMember
Beginning of Period, Non-vested , Weighted Average Grant Date Fair Value $ 56.92hcn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsNonvestedWeightedAverageGrantDateFairValue
/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis
= us-gaap_RestrictedStockMember
Vested, shares (553,000)hcn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriod
/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis
= us-gaap_RestrictedStockMember
Vested, Weighted Average Grant Date Fair Value $ 56.29hcn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriodWeightedAverageGrantDateFairValue
/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis
= us-gaap_RestrictedStockMember
Granted, shares 324,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis
= us-gaap_RestrictedStockMember
Granted, Weighted Average Grant Date Fair Value $ 57.59us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis
= us-gaap_RestrictedStockMember
Terminated, shares (5,000)hcn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTerminatedInPeriod
/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis
= us-gaap_RestrictedStockMember
Terminated, Weighted Average Grant Date Fair Value $ 57.2hcn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTerminatedInPeriodWeightedAverageGrantDateFairValue
/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis
= us-gaap_RestrictedStockMember
Ending Balance, Non-vested, shares 554,000hcn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsNonvestedNumber
/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis
= us-gaap_RestrictedStockMember
Ending of Period, Non-vested, Weighted Average Grant Date Fair Value $ 57.94hcn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsNonvestedWeightedAverageGrantDateFairValue
/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis
= us-gaap_RestrictedStockMember